Lensar, INC 10-Q quarterly reports

LENSAR, Inc. reports Q1 2026 financial results, highlighting a return to profitability driven by non-operating income from a terminated merger agreement.

LENSAR, Inc. reported a significantly wider net loss in Q3 2025 despite a 6% revenue increase, primarily driven by substantial acquisition-related costs for its pending merger with Alcon and increased warrant liabilities.

LENSAR, Inc. reports increased revenue and reduced net loss for Q2 2025, driven by ALLY System placements, while its acquisition by Alcon faces extended FTC review.

LENSAR, Inc. announces its Q1 2025 financial results, highlighting revenue growth and increased losses, while also addressing the ongoing merger agreement with Alcon.

LENSAR Inc. saw a significant revenue increase in Q3 2024, driven by strong product sales and procedure volume growth.

LENSAR Inc. saw a 5% increase in revenue year-over-year for the second quarter of 2024, driven by increased ALLY System sales and procedure volume, despite a net loss of $9.0 million.

LENSAR, Inc. saw a 28% increase in revenue year-over-year in the first quarter of 2024, driven by higher system sales and procedure volumes.